Alexandros is a cofounder and CEO at phagos. He is a serial tech entrepreneur with €25m+ raised from top tier VCs to fund cutting-edge startups he co-founded. Alexandros graduated from HEC Paris and started his career in EY's transaction advisory services.
El espectro de una era postantibiótica, en la que las infecciones comunes podrían volver a ser mortales, está emergiendo lentamente.
The spectre of a post-antibiotic era, where common infections could once again prove lethal, is rearing its head.
